Olokizumab Treatment of both Western and Asian Patients with Rheumatoid Arthritis who have Failed Anti-Tnf Treatment Results in Sustained Improvements in Patient-Reported Outcomes
| Autor: | I. Vasyutin, Patrick Durez, T. Kaviarasu, E Korneva, Yoshiya Tanaka, Daniel E. Furst, Roy Fleischmann, H Yamanaka, Mark C. Genovese, D Koloda, Tsutomu Takeuchi |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
030203 arthritis & rheumatology
medicine.medical_specialty Olokizumab business.industry Health Policy Public Health Environmental and Occupational Health Treatment results medicine.disease 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Rheumatoid arthritis Internal medicine medicine In patient Tumor necrosis factor alpha business |
| Zdroj: | Value in Health. 19:A543-A544 |
| ISSN: | 1098-3015 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect